Company intelligence / Profile preview

Insulet

Acton, Massachusetts, United Stateseas.org ↗

Ownership: Public · PODD
Employees: ~5000
Development stage: Commercial

Overview

Insulet’s Omnipod platform provides tubeless, wearable insulin pumps that deliver continuous subcutaneous insulin for up to three days. The flagship Omnipod 5 Automated Insulin Delivery System integrates with continuous glucose monitors (CGMs) to automatically adjust insulin dosing. The system has received regulatory approvals in the US and Europe, including CE mark for compatibility with Abbott FreeStyle Libre sensors and FDA clearance for smartphone control. Over 500,000 global customers use Omnipod products across more than 25 countries[1][2][3][5].

Therapeutic areas: OtherEndocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

Omnipod 5

Commercial

Indications: Type 1 diabetes, Type 2 diabetes

1 more asset in the full pipeline.

Request access →

Partnerships

Partnerships with biotechnology/pharmaceutical companies using customized forms of the Omnipod system for non-insulin drugs.Integration partnerships with CGM providers such as Dexcom and Abbott

Financials

Market cap: $9.9B
Total revenue: $801.7M
Enterprise value: $10.3B

Beyond the preview

Go deeper on Insulet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulet.

Explore the full profile